Market Place
Sourcing Support
Cue Biopharma Announces $30 Million Private Placement
30 Apr 2026 //
FIRSTWORD PHARMA
Cue Bio Expands Pipeline With Exclusive License
30 Apr 2026 //
FIRSTWORD PHARMA
Cue Biopharma Announces 1-For-30 Reverse Stock Split
22 Apr 2026 //
GLOBENEWSWIRE
Cue Biopharma Announces CEO Transition
27 Mar 2026 //
GLOBENEWSWIRE
Cue Biopharma To Host Virtual R&D Day Event On April 7, 2026
26 Mar 2026 //
GLOBENEWSWIRE
Cue Biopharma Reports Q4 & FY 2025 Results, Highlights
16 Mar 2026 //
GLOBENEWSWIRE
Cue Bio Reveals CUE-401 Preclinical Data For Autoimmune Diseases
17 Feb 2026 //
GLOBENEWSWIRE
Cue Biopharma Announces Pricing Of $10 Million Public Offering
19 Dec 2025 //
GLOBENEWSWIRE
Cue Biopharma Announces Proposed Public Offering
18 Dec 2025 //
GLOBENEWSWIRE
ImmunoScape Advances Next-Gen Cell Therapy, Adds Key Leaders
13 Nov 2025 //
BUSINESSWIRE
Cue Bio Reports Q3 2025 Financials & Business Updates
12 Nov 2025 //
GLOBENEWSWIRE
Cue Bio & Immunoscape Partner For Solid Tumor Cell Therapy
06 Nov 2025 //
GLOBENEWSWIRE
Cue Biopharma Announces 50% Response in Phase 1 Trial of CUE-101
16 Jul 2025 //
GLOBENEWSWIRE
Cue Biopharma Updates CUE-101 at DAVA 4th Hawaii Global Summit
01 Jul 2025 //
GLOBENEWSWIRE
Cue Biopharma gets FDA feedback on pre-IND document for CUE-401
24 Jun 2025 //
GLOBENEWSWIRE
Cue Biopharma to Host Virtual Investor Event on May 15, 2025
08 May 2025 //
GLOBENEWSWIRE
Boehringer, Cue Bio partner for autoimmune & inflammatory diseases
14 Apr 2025 //
GLOBENEWSWIRE
Cue Biopharma Prices $20M Public Offering
14 Apr 2025 //
GLOBENEWSWIRE
Cue Biopharma Announces Strategic Organizational Transition
14 Nov 2024 //
GLOBENEWSWIRE
Cue Biopharma CUE-101, CUE-102 Data in Head & Neck Cancer
08 Nov 2024 //
GLOBENEWSWIRE
Cue Biopharma Announces Presentations At SITC Annual Meeting
04 Oct 2024 //
GLOBENEWSWIRE
Cue Biopharma Announces Proposed Public Offering
26 Sep 2024 //
GLOBENEWSWIRE
Cue Biopharma Announces Pricing of $12.0 Million Public Offering
26 Sep 2024 //
GLOBENEWSWIRE
Cue Biopharma Appoints Lucinda Warren As CBO
09 Sep 2024 //
GLOBENEWSWIRE
Cue Biopharma Reports Q2 2024 Financial Results And Business Highlights
19 Aug 2024 //
GLOBENEWSWIRE
Cue Biopharma to Host Business Update Call and Webcast
13 Aug 2024 //
GLOBENEWSWIRE
Cue Biopharma: Updated CUE-101 Data In HPV+ Head And Neck Cancer At ASCO
04 Jun 2024 //
GLOBENEWSWIRE
Cue Bio To Present At Two June Healthcare Investor Conferences
03 Jun 2024 //
GLOBENEWSWIRE
Cue Biopharma Q1 2024 Financials And Business Highlights
09 May 2024 //
GLOBENEWSWIRE
Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
08 May 2024 //
GLOBENEWSWIRE
Cue Biopharma To Participate In Fireside Chat At Citizens JMP Conference
07 May 2024 //
GLOBENEWSWIRE
Cue Biopharma to Present at ASCO 2024 Annual Meeting
24 Apr 2024 //
GLOBENEWSWIRE
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
08 Apr 2024 //
GLOBENEWSWIRE
Cue Biopharma to Host Business Update Call and Webcast
02 Apr 2024 //
GLOBENEWSWIRE
Cue Biopharma™s Lead Clinical Asset, CUE-101, to be Featured
29 Feb 2024 //
GLOBENEWSWIRE
Cue to Present Corporate Update at the Oppenheimer 34th Annual Conference
06 Feb 2024 //
GLOBENEWSWIRE
Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101
03 Nov 2023 //
GLOBENEWSWIRE
Cue Biopharma Announces Upcoming Scientific Presentations at SITC
27 Sep 2023 //
GLOBENEWSWIRE
Cue Bio Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101
26 Sep 2023 //
GLOBENEWSWIRE
Cue Biopharma Reports Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
Cue Biopharma to Host Business Update Call and Webcast
02 Aug 2023 //
GLOBENEWSWIRE
Cue Biopharma to Present at the FOCIS 2023 Annual Meeting
14 Jun 2023 //
GLOBENEWSWIRE
Cue Biopharma to Host Investor Call
07 Jun 2023 //
GLOBENEWSWIRE
Cue Biopharma to Present at the Jefferies 2023 Global Healthcare Conference
05 Jun 2023 //
GLOBENEWSWIRE
Cue Bio Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101
25 May 2023 //
GLOBENEWSWIRE
Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference
08 May 2023 //
GLOBENEWSWIRE
Cue Biopharma Enters into Collaboration with Ono Pharmaceutical for CUE-401
22 Feb 2023 //
GLOBENEWSWIRE
Cue Bio Immuno-STAT Biologics to be Featured in Oxford University Presentation
16 Feb 2023 //
GLOBENEWSWIRE
